BACKGROUND: Multilayered alginate microcapsules with a permselective poly-L-ornithine membrane can be used for the dual purpose of encapsulating cells in the inner core and sustained release of angiogenic proteins from the outer layer. The aim of this study was to examine the encapsulation and release of a novel chimeric form of fibroblast growth factor-1 (FGF-1) from the outer layer of alginate microcapsules. METHODS: Heparin-binding growth-associated molecule bound to FGF-1 (HB-GAM/FGF-1) was encapsulated in the outer layer of multilayered alginate microbeads constructed using varying alginate conditions. The encapsulation and release of the chimera was quantified. RESULTS: The outer layer was able to encapsulate and release HB-GAM/FGF-1 for up to 30 days. The outer layer made with 1% alginate of high mannuronic acid content provided the fastest release, while 1.25% high guluronic acid content alginate displayed the longest duration of release. CONCLUSIONS: The outer layer of multilayered alginate microbeads can be used for the encapsulation and long-term release of HB-GAM/FGF-1.
BACKGROUND: Multilayered alginate microcapsules with a permselective poly-L-ornithine membrane can be used for the dual purpose of encapsulating cells in the inner core and sustained release of angiogenic proteins from the outer layer. The aim of this study was to examine the encapsulation and release of a novel chimeric form of fibroblast growth factor-1 (FGF-1) from the outer layer of alginate microcapsules. METHODS:Heparin-binding growth-associated molecule bound to FGF-1 (HB-GAM/FGF-1) was encapsulated in the outer layer of multilayered alginate microbeads constructed using varying alginate conditions. The encapsulation and release of the chimera was quantified. RESULTS: The outer layer was able to encapsulate and release HB-GAM/FGF-1 for up to 30 days. The outer layer made with 1% alginate of high mannuronic acid content provided the fastest release, while 1.25% high guluronic acid content alginate displayed the longest duration of release. CONCLUSIONS: The outer layer of multilayered alginate microbeads can be used for the encapsulation and long-term release of HB-GAM/FGF-1.
Authors: Clare R Ozawa; Andrea Banfi; Nicole L Glazer; Gavin Thurston; Matthew L Springer; Peggy E Kraft; Donald M McDonald; Helen M Blau Journal: J Clin Invest Date: 2004-02 Impact factor: 14.808
Authors: L Xue; A K Tassiopoulos; S K Woloson; D L Stanton; C S Ms; B Hampton; W H Burgess; H P Greisler Journal: J Vasc Surg Date: 2001-03 Impact factor: 4.268
Authors: Luke Brewster; Eric M Brey; Michael Addis; Lian Xue; Vicki Husak; Joan Ellinger; Christian C Haudenschild; Howard P Greisler Journal: Am J Surg Date: 2006-11 Impact factor: 2.565
Authors: Monica L Moya; Marc R Garfinkel; Xiang Liu; Stephanie Lucas; Emmanuel C Opara; Howard P Greisler; Eric M Brey Journal: J Surg Res Date: 2009-07-10 Impact factor: 2.192
Authors: Monica L Moya; Stephanie Lucas; Megan Francis-Sedlak; Xiang Liu; Marc R Garfinkel; Jung-Ju Huang; Ming-Huei Cheng; Emmanuel C Opara; Eric M Brey Journal: Microvasc Res Date: 2009-06-23 Impact factor: 3.514
Authors: J P McQuilling; J Arenas-Herrera; C Childers; R A Pareta; O Khanna; B Jiang; E M Brey; A C Farney; E C Opara Journal: Transplant Proc Date: 2011-11 Impact factor: 1.066
Authors: Monica L Moya; Michael Morley; Omaditya Khanna; Emmanuel C Opara; Eric M Brey Journal: J Mater Sci Mater Med Date: 2012-02-16 Impact factor: 3.896
Authors: Tram T Dang; Anh V Thai; Joshua Cohen; Jeremy E Slosberg; Karolina Siniakowicz; Joshua C Doloff; Minglin Ma; Jennifer Hollister-Lock; Katherine M Tang; Zhen Gu; Hao Cheng; Gordon C Weir; Robert Langer; Daniel G Anderson Journal: Biomaterials Date: 2013-05-07 Impact factor: 12.479